Clinical Trial Results

Showing: All studies [change]
Condition: Breast Cancer Location: East Providence, Rhode Island 25 trials found
New Search
Filter
Trial Phase
Study Type
Sacituzumab Govitecan +/- Pembrolizumab in Metastatic TNBC
PHASE2INTERVENTIONAL Stamford, Connecticut +4 more
RECRUITING
The CDK4/6 Inhibitor Dosing Knowledge (CDK) Study
PHASE3INTERVENTIONAL Chandler, Arizona +4 more
RECRUITING
ATEMPT 2.0: Adjuvant T-DM1 vs TH
PHASE2INTERVENTIONAL San Francisco, California +4 more
RECRUITING
TEMPUS ARIES: A Biobank Registry Platform Study in Oncology
N/AOBSERVATIONAL Birmingham, Alabama +4 more
RECRUITING
SDM POSSIBLE: A Breast Cancer Treatment Decision Aid for Women 70+ With Low-Risk Stage I Breast Cancers
NAINTERVENTIONAL Los Angeles, California +4 more
RECRUITING
Comparison of Breast Cancer Screening With CESM to DBT in Women With Dense Breasts
NAINTERVENTIONAL Birmingham, Alabama +4 more
RECRUITING
Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Los Angeles, California +4 more
RECRUITING
A Study to Learn About the Study Medicine Called PF-07248144 in Combination With Fulvestrant in People With HR-positive, HER2-negative Advanced or Metastatic Breast Cancer Who Progressed After a Prior Line of Treatment.
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Sacituzumab Govitecan In TNBC
PHASE2INTERVENTIONAL Boston, Massachusetts +4 more
RECRUITING
A Dyadic Intervention for Young Adult Patients With Cancer and Their Partner Caregivers
NAINTERVENTIONAL Boston, Massachusetts +3 more
RECRUITING
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
PHASE3INTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Mirai-MRI: Validation of AI Models for Breast Cancer Risk
NAINTERVENTIONAL San Diego, California +3 more
RECRUITING
S1703 Serum Tumor Marker Directed Disease Monitoring in Patients With Hormone Receptor Positive Her2 Negative Metastatic Breast Cancer
NAINTERVENTIONAL Anchorage, Alaska +4 more
RECRUITING
Adding Surgery and Radiation to the Usual Treatment for HER2-Positive Breast Cancer That Had Already Spread at Diagnosis
PHASE3INTERVENTIONAL Jonesboro, Arkansas +4 more
RECRUITING
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
N/AOBSERVATIONAL San Francisco, California +4 more
RECRUITING
An Observational Study On TheAccuracy Of Whole-Body Magnetic Resonance Imaging (Wb-Mri) ScreeningTo Predict Clinically Significant Diagnoses In General Population Subjects Interested In Proactive And Advanced General Preventive Healthcare.
N/AOBSERVATIONAL Watertown, Massachusetts
RECRUITING
Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer
PHASE2INTERVENTIONAL Washington D.C., District of Columbia +4 more
RECRUITING
A Study Evaluating the Efficacy and Safety of Multiple Treatment Combinations in Participants With Breast Cancer
PHASE1, PHASE2INTERVENTIONAL Duarte, California +4 more
RECRUITING
Positron Emission Tomography (PET) Imaging of Thrombosis
PHASE1INTERVENTIONAL Boston, Massachusetts
RECRUITING
Phase 1a and Phase 2 Study for Safety, Preliminary Efficacy, PK and PD of ST-067
PHASE1, PHASE2INTERVENTIONAL Scottsdale, Arizona +4 more
RECRUITING
Refining Local-Regional Therapy for IBC
NAINTERVENTIONAL Boston, Massachusetts
RECRUITING
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Peripheral Neuropathy Receiving Paclitaxel for Breast Cancer
N/AOBSERVATIONAL Boston, Massachusetts
RECRUITING
The Evaluation of PC14586 in Patients With Advanced Solid Tumors Harboring a TP53 Y220C Mutation (PYNNACLE)
PHASE1, PHASE2INTERVENTIONAL Irvine, California +4 more
RECRUITING
ACTengine® IMA203/IMA203CD8 as Monotherapy or in Combination With Nivolumab in Recurrent and/or Refractory Solid Tumors
PHASE1, PHASE2INTERVENTIONAL Stanford, California +4 more
RECRUITING
Study of Abemaciclib and Elacestrant in Participants With Brain Metastasis Due to ER+/HER-2- Breast Cancer
PHASE1, PHASE2INTERVENTIONAL Fullerton, California +4 more
RECRUITING
Filter Trials
Trial Phase
Study Type